Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Short Interest Update
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 3,660,000 shares, a decrease of 17.6% from the March 15th total of 4,440,000 shares. Based on an average trading volume of 426,500 shares, […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 3,660,000 shares, a decrease of 17.6% from the March 15th total of 4,440,000 shares. Based on an average trading volume of 426,500 shares, […]